Bone marrow transplantation for children with acute myelogenous leukaemia in the first complete remission

European Journal of Cancer

Volumn 36, Issue 3, 2000, Pages 368-375

  Matsuyama, T ^a   Horibe, K ^a,b   Kato, K ^a   Kojima, S ^a,b  

^a JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute myelogenous leukaemia; Bone marrow transplantation; Childhood; First complete remission; Melphalan

Indexed keywords

ACICLOVIR; ALANINE AMINOTRANSFERASE; ANTHRACYCLINE ANTIBIOTIC AGENT; ASPARTATE AMINOTRANSFERASE; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; CYTOMEGALOVIRUS ANTIBODY; ETOPOSIDE; FOLINIC ACID; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN; METHOTREXATE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW TRANSPLANTATION; CHEMOTHERAPY; CHILD; CLINICAL PROTOCOL; CONDITIONING; DIARRHEA; FEMALE; FEVER; GRAFT VERSUS HOST REACTION; GRANULOCYTOPENIA; HEMORRHAGIC CYSTITIS; HUMAN; INFANT; KIDNEY DISEASE; LEUKEMIA REMISSION; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MUCOSA INFLAMMATION; PNEUMONIA; PRIORITY JOURNAL; RELAPSE; RETROSPECTIVE STUDY; STOMATITIS; SURVIVAL; TREATMENT OUTCOME; VOMITING; WHOLE BODY RADIATION;

BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; HUMANS; INFANT; INFANT, NEWBORN; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; RECURRENCE; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0034002135     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(99)00329-9     Document Type: Article

References (29)

1. Gorin NC, Labopin M, Fouillard L, et al. Retrospective evaluation of autologous bone marrow transplantation vs allogeneic bone marrow transplantation from an HLA identical related donor in acute myelocytic leukemia. A study of the European Cooperative Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 1996, 18, 111-117.
2. Amadori S, Testi AM, Arico M, et al. Prospective comparative study of bone marrow transplantation and postremission chemotherapy for childhood acute myelogenous leukemia. J Clin Oncol 1993, 11, 1046-1054.
3. Ravindranath Y, Yeager AM, Chang MN, et al. Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. N Engl J Med 1996, 334, 1428-1434.
4. Woods WG, Kobrinsky N, Buckley J, et al. Intensively timed induction therapy followed by autologous or allogeneic bone marrow transplantation for children with acute myeloid leukemia or myelodysplastic syndrome: a Childrens Cancer Group Pilot Study. J Clin Oncol 1993, 11, 1448-1457.
5. Ortega JJ, Olive T, Heredia CD, Coll MT, Bastida P, Massuet LI. Allogeneic and autologous bone marrow transplantation in AML in first remission. The Spanish experience. Bone Marrow Transplant 1996, 18(Suppl. 2), 53-58.
6. Kigasawa H, Akiyama Y, Ohira M, et al. Prospective comparison between postinduction chemotherapy and various types of stem-cell transplants for childhood acute myeloid leukemia using Japan Cooperative Protocol ANLL 91. Med Pediatr Oncol 1998, 31, 225(abstract).
7. Creutzig U, Ritter J, Schellong G. Identification of two risk groups in childhood acute myelogenous leukemia after therapy intensification in study AML-BFM-83 as compared with study AML-BFM-78. Blood 1990, 75, 1932-1940.
8. Stevens RF, Hann IM, Wheatley K, Gray RG. Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukaemia: results of the United Kingdom Medical Research Council's 10th AML trial. Br J Haematol 1998, 101, 130-140.
9. Dini G, Cornish JM, Gadner H, et al. Bone marrow transplant indications for childhood leukemias: achieving a consensus. Bone Marrow Transplant 1996, 18(Suppl. 2), 4-7.
10. Lausen BF, Heilmann C, Vindeløv L, et al. Outcome of acute lymphoblastic leukaemia in Danish children after allogeneic bone marrow transplantation. Superior survival following transplantation with matched unrelated donor grafts. Bone Marrow Transplant 1998, 22, 325-330.
11. Stahnke K, Boos J, Bender-Götze C, Ritter J, Zimmermann M, Creutzig U. Duration of first remission predicts remission rates and long-term survival in children with relapsed acute myelogenous leukemia. Leukemia 1998, 12, 1534-1538.
12. Sanders JE, Thomas ED, Buckner CD, et al. Marrow transplantation for children in first remission of acute nonlymphoblastic leukemia: an update. Blood 1985, 66, 460-462.
13. Liesner RJ, Leiper AD, Hann IM, Chessells JM. Late effects of intensive treatment for acute myeloid leukemia and myelodysplasia in childhood. J Clin Oncol 1994, 12, 916-924.
14. Maraninchi D, Pico JL, Hartmann O, et al. High-dose melphalan with or without marrow transplantation: a study of dose-effect in patients with refractory and/or relapsed acute leukemias. Cancer Treat Rep 1986, 70, 445-448.
15. Tutschka PJ, Copelan EA, Klein JP. Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen. Blood 1987, 70, 1382-1388.
16. Gorin NC, Aegerter P, Auvert B. Autologous bone marrow transplantation (ABMT) for acute leukaemia in remission: an analysis on 1322 cases. Bone Marrow Transplant 1989, 4(Suppl. 2), 3-5.
17. Gorin NC, Aegerter P, Auvert B, et al. Autologous bone marrow transplantation for acute myelocytic leukemia in first remission: a European survey of the role of marrow purging. Blood 1990, 75, 1606-1614.
18. Calderwood S, Doyle JJ, Hitzler JK, Saunders EF, Freedman MH. Administration of recombinant human granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation in children with acute myelogenous leukemia: a note of caution. Bone Marrow Transplant 1996, 18, 87-91.
19. Favre C, Nardi M, Dini G, et al. The role of total body irradiation (TBI). Bone Marrow Transplant 1996, 18(Suppl. 2), 71-74.
20. Vignetti M, Rondelli R, Locatelli F, et al. Autologous bone-marrow transplantation in children with acute myeloblastic leukemia: report from the Italian National Pediatric Registry (AIEOP-BMT). Bone Marrow Transplant 1996, 18(Suppl. 2), 59-62.
21. Feig SA, Lampkin B, Nesbit ME, et al. Outcome of BMT during first complete remission of AML: a comparison of two sequential studies by the Childrens Cancer Group. Bone Marrow Transplant 1993, 12, 65-71.
22. Dini G, Boni L, Abla O, et al. Allogeneic bone marrow transplantation in children with acute myelogenous leukemia in first remission. Bone Marrow Transplant 1994, 13, 771-776.
23. Michel G, Gluckman E, Esperou-Bourdeau H, et al. Allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: impact of conditioning regimen without total-body irradiation - a report from the Société Française de Greffe de Moelle. J Clin Oncol 1994, 12, 1217-1222.
24. Klingebiel T, Pession A, Paolucci P, Rondelli R, Niethammer D. Autologous versus allogeneic BMT in AML: the European experience. Report of the EBMT - Pediatric Diseases Working Party. Bone Marrow Transplant 1996, 18(Suppl. 2), 49-52.
25. Nesbit ME, Buckley JD, Feig SA, et al. Chemotherapy for induction of remission of childhood acute myeloid leukemia followed by marrow transplantation or multiagent chemotherapy: a report from the Chidrens Cancer Group. J Clin Oncol 1994, 12, 127-135.
26. Ringdén O, Sundberg B, Lönnqvist B, Tollemar J, Gahrton G, Nilsson B. Allogeneic bone marrow transplantation for leukemia: factors of importance for long-term survival and relapse. Bone Marrow Transplant 1988, 3, 281-290.
27. Tiedemann K, Waters KD, Tauro GP, Tucker D, Ekert H. Results of intensive therapy in childhood acute myeloid leukemia, incorporating high-dose melphalan and autologous bone marrow transplantation in first complete remission. Blood 1993, 82, 3730-3738.
28. Martino R, Badell I, Brunet S, et al. High-dose busulfan and melphalan before bone marrow transplantation for acute nonlymphoblastic leukemia. Bone Marrow Transplant 1995, 16, 209-212.
29. Teinturier C, Hartmann O, Valteau-Couanet D, Benhamou E, Bougneres PF. Ovarian function after autologous bone marrow transplantation in childhood: high-dose busulfan is a major cause of ovarian failure. Bone Marrow Transplant 1998, 22, 989-994.